HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 28 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -75.0% | 1,029 | -80.8% | 0.00% | – |
| Q3 2019 | $4,000 | -63.6% | 5,347 | -17.1% | 0.00% | – |
| Q2 2019 | $11,000 | -68.6% | 6,450 | -53.7% | 0.00% | – |
| Q1 2019 | $35,000 | 0.0% | 13,925 | +0.0% | 0.00% | – |
| Q4 2018 | $35,000 | -54.5% | 13,922 | -8.3% | 0.00% | -100.0% |
| Q3 2018 | $77,000 | +1825.0% | 15,189 | +1282.1% | 0.00% | – |
| Q2 2018 | $4,000 | – | 1,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |